Peri-operative Analgesia for Single-incision Laparoscopic Appendectomy (PAMAL)
Comparative Retrospective Study on the Different Analgesic Modalities Used for Single-incision Laparoscopic Appendectomy
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Contacts and Locations
Study Contact
Study Contact
- Name: Jeanne Goulin, MD
- Phone Number: +33 2 41 35 42 90
- Email: jeanne.goulin@chu-angers.fr
Study Contact Backup
- Name: Françoise Schmitt, MD-PhD
- Phone Number: +33 2 41 35 42 90
- Email: FrSchmitt@chu-angers.fr
Study Locations
-
-
-
Angers, France, 49933
- Angers University Hospital
-
Contact:
- Françoise SCHMITT, MD, PhD
- Phone Number: +33241354290
- Email: FrSchmitt@chu-angers.fr
-
Contact:
- Jeanne GOULIN, MD
- Phone Number: (+33)241354290
- Email: jeanne.goulin@chu-angers.fr
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- All patients operated on for appendectomy by SILAP, aged 15 years and under in our pediatric surgical center.
Exclusion Criteria:
- Patients aged 16 years or more.
- Patients with concomitant pathologies potentially inducing hyper- or hypoesthesia (e.g. cancers, spinal cord injury, etc...)
- Patients with contraindications for the use of IV analgesics.
- patients operated on for appendectomy through 3-ports laparoscopy or open surgery.
- Opposition of the patients and their representative to the study.
Study Plan
How is the study designed?
Design Details
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
SILAP patients
This cohort is composed by all pediatric patients operated on for SILAP between January 1st, 2012 and August 31, 2022.
|
Appendectomy performed through transumbilical single access laparoscopy, consisting in the removal of the appendix.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
To assess the level of pain after SILAP during the 24 first hours after surgery.
Time Frame: Up to 16 years of age. From the date of surgery until the end of hospital stay, assessed up to 16 years of age
|
Objectified by the quantity of level 2-3 (in morphin equivalent) analgesic used up to 24 hours after surgery.
|
Up to 16 years of age. From the date of surgery until the end of hospital stay, assessed up to 16 years of age
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
To assess the level of pain as measured by the different pain scales routinely used.
Time Frame: Up to 16 years of age. From the date of surgery until the end of hospital stay, assessed up to 16 years of age
|
Objectified by the higher level of pain quoted during the first 24 hours after surgery.
|
Up to 16 years of age. From the date of surgery until the end of hospital stay, assessed up to 16 years of age
|
|
To assess the level of pain during the initial post-operative recovery room stay.
Time Frame: Up to 16 years of age. From the date of surgery until the end of hospital stay, assessed up to 16 years of age
|
Objectified by the higher level of pain quoted during the first 24 hours after surgery and by the amount of level 2-3 analgesic used.
|
Up to 16 years of age. From the date of surgery until the end of hospital stay, assessed up to 16 years of age
|
|
To assess the level of pain after the 24 first hours and until hospital release.
Time Frame: Up to 16 years of age. From the date of surgery until the end of hospital stay, assessed up to 16 years of age
|
Objectified by the higher level of pain quoted from 24 hours post-operative to hospital discharge, and by the amount of level 2-3 analgesic used.
|
Up to 16 years of age. From the date of surgery until the end of hospital stay, assessed up to 16 years of age
|
|
To assess the different peri-operative local and loco-regional analgesia modalities used and to compare their efficiency.
Time Frame: Up to 16 years of age. From the date of surgery until the end of hospital stay, assessed up to 16 years of age
|
Objectified by the amount of level 2-3 analgesics used in post-operative recovery room and during hospital stay.
|
Up to 16 years of age. From the date of surgery until the end of hospital stay, assessed up to 16 years of age
|
|
To assess the types and gravity of peri-operative and post-analgesia complications.
Time Frame: Up to 16 years of age. From the date of surgery until the end of hospital stay, assessed up to 16 years of age
|
Objectified by the description of complications encountered and classified with the Clavien and Dindo gravity scale for surgical complications.
|
Up to 16 years of age. From the date of surgery until the end of hospital stay, assessed up to 16 years of age
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Françoise Schmitt, MD, PhD, University Hospital of Angers
Publications and helpful links
General Publications
- Goodman LF, Lin AC, Sacks MA, McRae JJLH, Radulescu A, Khan FA. Single site versus conventional laparoscopic appendectomy: some pain for no gain? J Surg Res. 2021 Aug;264:321-326. doi: 10.1016/j.jss.2021.03.010. Epub 2021 Apr 10.
- Binet A, Braik K, Lengelle F, Laffon M, Lardy H, Amar S. Laparoscopic one port appendectomy: Evaluation in pediatric surgery. J Pediatr Surg. 2018 Nov;53(11):2322-2325. doi: 10.1016/j.jpedsurg.2017.12.018. Epub 2017 Dec 27.
Study record dates
Study Major Dates
Study Start (Estimated)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 2022-124
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.